11:56 AM EST - Stem Cell Therapeutics Corp. : posted fiscal 2009 net loss of $4.7 million or $0.03 per share, narrower than $5.6 million or $0.05 per share in the prior-year period. Stem Cell Therapeutics Corp.
shares V.SSS are trading down $0.005 at $0.29.
